Ticarcillin is a carboxypenicillin. It is almost always sold and used in combination with clavulanate as ticarcillin or clavulanic acid. Because it is a penicillin, it also falls within the larger class of beta-lactam antibiotics. Its main clinical use is as an injectable antibiotic for the treatment of Gram-negative bacteria, particularly Pseudomonas aeruginosa. It is also one of the few antibiotics capable of treating Stenotrophomonas maltophilia infections.

Market Analysis and Insights: Global Ticarcillin Market
In 2020, the global Ticarcillin market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Ticarcillin Scope and Market Size
The global Ticarcillin market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Ticarcillin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Patent
Generic

Segment by Application
Hospital
Drug Store

By Company
Shanxi C and Y
GlaxoSmithKline
Zoetis
Aspen Pharmacare
Biopharma S.R.L
Cathay Drug
General Sanyang Pharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE